Article Details

BioSyent Inc. (RX) Analysts See $0.11 EPS as of March, 20

Retrieved on: 2019-03-06 01:26:15

Tags for this article:

Click the tags to see associated articles and topics

BioSyent Inc. (RX) Analysts See $0.11 EPS as of March, 20. View article details on HISWAI:

Excerpt

<div>On March, 20 WallStreet anticipated BioSyent Inc. (CVE:RX)'s earnings ... Inc (TSE:ACB) CCO Cam Battley on Spin-out and <b>Canopy Growth Corp</b> ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up